WELLESLEY, Mass., Dec. 17, 2018 /PRNewswire/ -- Essential to drug discovery and development, disease management and in-vitrodiagnostics, the global biomarkers market has vastly expanded as licensing, partnerships and acquisitions deals have significantly increased, according to BCC Research.
The global biomarkers market was valued at $74.5 billion
Key players in the industry include Abbott Laboratories, Bio-Rad Laboratories, CareDx, Epigenomics AG, GE Healthcare, Genomic Health, Illumina, Life Diagnostics, Myriad Genetics and many others.
"In the biomarkers sector, collaborations and partnerships can help a firm overcome challenges during the development stage and can help introduce new products and tests into the market. Companies collaborate to accelerate R&D activities, including biomarker identification and discovery as well as assay/technology development," said analyst Dr. Marianna Tcherpakov.
Oncology Sector Drives Biomarker Licensing and Collaborations
The oncology sector is the most active in biomarker licensing and collaborations. In general, the main research and product development efforts in this sector are focused on prostate, bladder, breast, melanoma, lung and ovarian cancers.
Dr. Marianna Tcherpakov's further discussed the global biomarkers market in a recent webinar. For more information on biomarkers deals and trends, refer to the following blog post "Biomarkers: Advancing Drug Development, Dominating the Market" based on her talking points.
Editors/reporters requesting analyst interviews should contact Eric Surber at email@example.com.
About BCC Research
BCC Research is a publisher of market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering major industrial and technology sectors, including emerging markets. For more information about BCC Research, please visit bccresearch.com. Follow BCC Research on Twitter at @BCCResearch.
Biomarker Deals: Terms, Value and Trends, 2008-2018
View original content:http://www.prnewswire.com/news-releases/global-biomarkers-market-sees-rapid-growth-as-deals-develop-300767180.html
SOURCE BCC Research
Subscribe to our Free Newsletters!